Background Respiratory virus infection is a common cause of hospitalisation in adults. Rapid
point-of-care testing (POCT) for respiratory viruses might improve clinical care by reducing …

Background Development of an effective vaccine against the pathogenic blood-stage infection
of human malaria has proved challenging, and no candidate vaccine has affected blood-…

… We congratulate Nathan Brendish and colleagues for doing their trial during the first COVID-19
wave. The reduction in turnaround time in the point-of-care testing group was impressive, …

In the past few weeks, there has been a great deal of trepidation among the public about the
impact of children returning to school on the transmission of severe acute respiratory …

The development of a highly effective vaccine remains a key strategic goal to aid the control
and eventual eradication of Plasmodium falciparum malaria. In recent years, the reticulocyte-…

Objectives The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the
overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral …

Influenza virus infection causes seasonal epidemics and occasional pandemics, leading to
huge morbidity and mortality worldwide. Vaccination against influenza is needed annually as …

Objectives Most reports describing the characteristics of patients hospitalised with COVID-19
lack a comparator group. We compared clinical characteristics, symptoms, and outcomes of …

Background Transmission blocking vaccines targeting the sexual-stages of the malaria
parasite could play a major role to achieve elimination and eradication of malaria. The …

Introduction Management of the COVID-19 pandemic is hampered by long delays associated
with centralised laboratory PCR testing. In hospitals this leads to poor patient flow and …